November 16, 2020 New drug can improve fertility in women with reproductive health problems A drug that acts via the natural ‘kisspeptin’ hormone system in the body has the potential to treat reproductive health problems in women. Twenty-four women were injected with a drug called MVT-602 which targets the kisspeptin system to stimulate reproductive hormones that affect fertility, sexual development and menstruation. The naturally occurring form of kisspeptin called […]
Patients taking statins experience similar side effects from dummy pills People taking dummy pills and statins experienced similar side effects in a new study. In a clinical trial of 60 patients, led by researchers at Imperial College London and clinicians at Imperial College Healthcare NHS Trust, 90 per cent of symptoms experienced by patients whilst taking statins were all present when they took placebo pills. […]
November 13, 2020 Cancer patients at increased risk of severe outcomes from COVID-19 Patients with cancer have a much higher risk of severe outcomes and death from COVID-19 than non-cancer patients. In an analysis of 15 research studies involving more than 3,000 patients around the world, researchers found that cancer patients who contracted COVID-19 had a 23 per cent risk of mortality compared to non-cancer patients with COVID […]
New Unit to advance cancer prevention research and strategies A new Unit focusing on cancer prevention research and strategies has launched at Imperial and The Institute of Cancer Research, London. The Cancer Epidemiology and Prevention Unit (CEPRU) is a joint initiative between Imperial College London and The Institute of Cancer Research. Its vision is to be a global leader in advancing research on the […]